Ischemic Stroke, Acute
82
30
31
21
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 82 trials
100.0%
+13.4% vs benchmark
34%
28 trials in Phase 3/4
10%
2 of 21 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 21 completed trials
Clinical Trials (82)
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
Benson Relaxation for Anxiety, Depression, and Insomnia After Stroke
Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
Artificial Intelligence Support for Stroke
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke
Tirofiban Combined With Aspirin in Moderate Ischemic Stroke
A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke
MyStroke for Stroke Survivors and Caregivers
Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy
TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
Clinical Efficacy and Mechanism Research of Getong Tongluo Capsule in Ischemic Stroke
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
Brain-Oscillation-Synchronized Stimulation to Enhance Motor Recovery in Early Subacute Stroke
A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke
Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice